Resources

For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

Peptide Chemistry

PurePep Chorus

Antibody & Protein Engineering

SARS-CoV-2 Research Reagents

Gene Therapy Development

Inciting Rapid Standardisation in Cell and Gene Therapy Manufacturing

Can the cell and gene therapy field create industry consensus on a more detailed level? In this Insight Article, Jorgen Magnus, Strategic Program Lead of Cell and Gene Therapy at Bayer, highlights the promise of process mapping for reaching a harmonised approach to development and manufacturing standards.
Antibody & Protein Engineering

T Cell Engagement and Redirection – Strategies, Methods, and T Cell Design

Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our February Discussion Group addressing ‘T Cell Engagement and Redirection – Strategies, Methods, and T Cell Design’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
Oligo Chemistry

Optimising Oligonucleotide Therapies: Efficacy, Targetability, and Precision Medicine

With efficacy, safety, and targetability being the top three challenges facing the nucleotide-based therapeutic industry today, will oligo-based therapies fulfil their potential as a clinical modality?
Oligo Chemistry

Oligonucleotide Chemistry & Therapeutics Symposium: Market Trends and Industry Challenges

The first of its kind, the Oligonucleotides: Chemistry & Therapeutics Symposium was a hit. We sat down with an advisory group of leading industry experts to hear their thoughts on the future of the Oligonucleotide drug industry as well as some of its key market trends and challenges.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery